Absci ABSI
NASDAQ ABSI
$8.93 +0.39 (+4.51%)
As of: Oct 20, 2026 · 12:00 PM EDT

Absci (ABSI) Receivables (2023 - 2025)

Updated

Absci (ABSI) reported Receivables of $1 million for Q3 2025, up 42.9% from the prior quarter.

Analysis

Absci (ABSI) Receivables (2023 - 2025) Analysis & Trends

At the end of FY2023, Absci posted Receivables of $2.19 million.

  • Five-year quarterly Receivables spans a low of $700,000 in Q2 2025 and a high of $2.19 million in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,160.09 Bn 1,128.68 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 624.76 Bn 543.28 Bn 17.26 Bn 19.05 Bn
3 AbbVie 511.79 Bn 484.90 Bn 12.70 Bn 13.82 Bn
4 Merck 366.25 Bn 320.63 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 297.28 Bn 261.27 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.26 Bn 234.95 Bn 12.86 Bn 15.68 Bn
7 Amgen 234.84 Bn 190.23 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 193.93 Bn 168.13 Bn 6.22 Bn 5.06 Bn
9 Pfizer 171.68 Bn 118.33 Bn 10.94 Bn 12.49 Bn
10 Absci 1.40 Bn 775.52 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 1.00 Mn
Jun 30, 2025 700,000.00
Mar 31, 2025 1.38 Mn
Dec 31, 2023 2.19 Mn
API Access

Absci Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=ABSI&period=max&api_key=YOUR_API_KEY